Stephen Mathew

About Stephen Mathew

Stephen Mathew, With an exceptional h-index of 15 and a recent h-index of 12 (since 2020), a distinguished researcher at University of North Texas Health Science Center, specializes in the field of Cancer, Immunology, Medicine, Microbiology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Differential expression of immune receptors in pediatric Acute Lymphoblastic Leukemia (ALL)

Differential Expression of LLT1, SLAM Receptors CS1 and 2B4 and NCR Receptors NKp46 and NKp30 in Pediatric Acute Lymphoblastic Leukemia (ALL)

Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal

Blocking PCNA interaction with NKp44 enhances primary natural killer cell-mediated lysis of triple-negative breast cancer cells

Expression of Immune Receptors in Response to Chemotherapy Treatment in B and T Acute Lymphoblastic Leukemia

Analysis of expression and function of LLT1 (CLEC2D) in Ewing sarcoma

NK cell isolation and cytotoxicity by radioactive chromium release assay and DELFIA-EuTDA cytotoxicity assay

Natural killer cell-mediated immunotherapy for leukemia

Stephen Mathew Information

University

Position

Assistant Professor Fort Worth TX USA

Citations(all)

770

Citations(since 2020)

406

Cited By

488

hIndex(all)

15

hIndex(since 2020)

12

i10Index(all)

18

i10Index(since 2020)

14

Email

University Profile Page

Google Scholar

Stephen Mathew Skills & Research Interests

Cancer

Immunology

Medicine

Microbiology

Top articles of Stephen Mathew

Differential expression of immune receptors in pediatric Acute Lymphoblastic Leukemia (ALL)

The Journal of Immunology

2023/5/1

Differential Expression of LLT1, SLAM Receptors CS1 and 2B4 and NCR Receptors NKp46 and NKp30 in Pediatric Acute Lymphoblastic Leukemia (ALL)

International Journal of Molecular Sciences

2023/2/15

Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal

2023/1/22

Blocking PCNA interaction with NKp44 enhances primary natural killer cell-mediated lysis of triple-negative breast cancer cells

American Journal of Cancer Research

2023

Expression of Immune Receptors in Response to Chemotherapy Treatment in B and T Acute Lymphoblastic Leukemia

2023

Stephen Mathew
Stephen Mathew

H-Index: 10

Analysis of expression and function of LLT1 (CLEC2D) in Ewing sarcoma

The Journal of Immunology

2022/5/1

NK cell isolation and cytotoxicity by radioactive chromium release assay and DELFIA-EuTDA cytotoxicity assay

2022/3/29

Natural killer cell-mediated immunotherapy for leukemia

2022/2/8

Compositions and methods for activation of NK cells killing of prostate cancer and breast cancer cells

2021/9/7

The many faces of innate immunity in SARS-CoV-2 infection

2021/6/4

Roles of NK cell receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in cancer

2020/7/1

Overexpression of LLT1 (CLEC2D) in childhood Acute Lymphoblastic Leukemia (ALL)

The Journal of Immunology

2020/5/1

See List of Professors in Stephen Mathew University(University of North Texas Health Science Center)